Sponsor:
Cedars-Sinai Medical Center
Code:
NCT06567821
Conditions
Chronic Maxillary Rhinosinusitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
RELIEVA SPINPLUS® NAV Balloon Sinusplasty System
Brief summary:
Conditions
Chronic Maxillary Rhinosinusitis
Study ID
NCT06567821
Start date
Sep 4, 2024
Status verified date
Mar, 2026
Completion date
Dec 31, 2027
Anticipated
Primary completion date
Oct 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Primary purpose
Other
Interventions
RELIEVA SPINPLUS® NAV Balloon Sinusplasty System
Primary outcome measure
Central contacts
Locations
Cedars Sinai
Recruiting
Los Angeles, California, United States, 90048
Contacts
Principal Investigator:
Dennis M Tang, MD
Sponsor
Cedars-Sinai Medical Center
Last update posted
Mar 11, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Cedars-Sinai Medical Center on 2026-03-11.